The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension

被引：0
|
作者：
Samantha L. Wronski
Margaret Mordin
Kim Kelley
Rebekah H. Anguiano
Peter Classi
Eric Shen
Scott Manaker
机构：
[1] RTI Health Solutions,Department of Pharmacy Practice
[2] RTI Health Solutions,Department of Medicine
[3] Rx Trusted Advisors,undefined
[4] University of Illinois at Chicago,undefined
[5] United Therapeutics,undefined
[6] Perelman School of Medicine at the University of Pennsylvania,undefined
来源：
Lung | 2020年 / 198卷
关键词：
PAH; Noninvasive endpoint; Risk assessment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：65 / 86
页数：21
相关论文
共 50 条
  • [41] Impact of Initial Therapeutic Strategy on Long-Term Outcomes in Pulmonary Arterial Hypertension: An Analysis of the PHSANZ Registry
    Kearney, K.
    Lavender, M.
    Cordina, R.
    Collins, N.
    Corrigan, C.
    Dwyer, N.
    Feenstra, J.
    Keating, D.
    McWilliams, T.
    Williams, T.
    Whitford, H.
    Wrobel, J.
    Keogh, A.
    Kotlyar, E.
    Lau., E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S27 - S28
  • [42] Impact of initial therapeutic strategy on long-term outcomes in pulmonary arterial hypertension: An analysis of the PHSANZ registry
    Kearney, K.
    Lavender, M.
    Cordina, R.
    Collins, N.
    Corrigan, C.
    Dwyer, N.
    Feenstra, J.
    Keating, D.
    McWilliams, T.
    Williams, T.
    Whitford, H.
    Whyte, K.
    Weintraub, R.
    Wrobel, J.
    Keogh, A.
    Kotlyar, E.
    Lau, E.
    RESPIROLOGY, 2022, 27 : 50 - 50
  • [43] LONG-TERM OUTCOMES OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AND CONNECTIVE TISSUE DISEASE TREATED WITH INTRAVENOUS EPOPROSTENOL
    Shirai, Y.
    Yasuoka, H.
    Takeuchi, T.
    Satoh, T.
    Kuwana, M.
    RHEUMATOLOGY, 2012, 51 : 60 - 61
  • [44] Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study
    Weatherald, Jason
    Chaumais, Marie-Camille
    Savale, Laurent
    Jais, Xavier
    Seferian, Andrei
    Canuet, Matthieu
    Bouvaist, Helene
    Magro, Pascal
    Bergeron, Anne
    Guignabert, Christophe
    Sitbon, Olivier
    Simonneau, Gerald
    Humbert, Marc
    Montani, David
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (01)
  • [45] Long-term inhaled iloprost use in children with pulmonary arterial hypertension
    Alehan, Dursun
    Yildirim, Isil
    Sahin, Murat
    Ozkutlu, Suheyla
    Ozer, Sema
    Karagoz, Tevfik
    CARDIOLOGY IN THE YOUNG, 2012, 22 (04) : 396 - 403
  • [46] Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
    Calcaianu, George
    Calcaianu, Mihaela
    Canuet, Matthieu
    Enache, Irina
    Kessler, Romain
    PULMONARY CIRCULATION, 2017, 7 (02) : 439 - 447
  • [47] Severe Pediatric Pulmonary Arterial Hypertension. Long-Term Outcomes of Reverse Potts Shunt and Transplantation
    Valdeolmillos, E.
    Le Pavec, J.
    Audie, M.
    Savale, L.
    Jais, X.
    Feuillet, S.
    Sitbon, O.
    Mercier, O.
    Petit, J.
    Humbert, M.
    Fadel, E.
    Belli, E.
    Hascoet, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S11 - S11
  • [48] Long-Term Hepatic Safety of Ambrisentan in Patients With Pulmonary Arterial Hypertension
    Ben-Yehuda, Ori
    Pizzuti, David
    Brown, Andrea
    Littman, Marcus
    Gillies, Hunter
    Henig, Noreen
    Peschel, Tobias
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (01) : 80 - U105
  • [49] Long-Term Ambrisentan Therapy for Pulmonary Arterial Hypertension: Comparison by Etiology
    Pulido, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [50] Long-term continuous subcutaneous treprostinil therapy for pulmonary arterial hypertension
    Skoro-Sajer, N
    Harja, E
    Bonderman, D
    Rezaie-Majd, S
    Machherndl, S
    Kneussl, M
    Lang, MI
    EUROPEAN HEART JOURNAL, 2003, 24 : 483 - 483
12345